KRYSTAL BIOTECH INC (KRYS) insider trading activity (SEC Form 4). Over the trailing 90 days, KRYS insiders filed 0 purchases totalling $0 and 4 sales totalling $15.9M — net SELLING of $15.9M. Most recent filing: Jun 26, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Thomas John Charles | EVP, GC | S SaleOE | — | $347.27 | $347K | filing |
| Jun 5, 2026 | Krishnan Krish S | Pres, CEO, 10% | S Sale | — | $308.12 | $7.7M | filing |
| Jun 5, 2026 | Krishnan Suma | Pres, R, D, 10% | S Sale | — | $308.11 | $7.7M | filing |
| May 27, 2026 | Thomas John Charles | EVP, GC | S Sale | — | $302.03 | $194K | filing |